Stockscreener 앱 받기
12.02
0.17%
-0.02
시간 외 거래:
12.01
-0.010
-0.08%
전일 마감가:
$12.04
열려 있는:
$11.99
하루 거래량:
321.20K
Relative Volume:
0.45
시가총액:
$655.85M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.67%
1개월 성능:
+2.30%
6개월 성능:
-2.75%
1년 성능:
+0.00%
1일 변동 폭
$11.96
$12.25
1주일 범위
$10.64
$12.25
52주 변동 폭
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
명칭
Bicara Therapeutics Inc
전화
617-468-4219
주소
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
12.02 | 656.94M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-05-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 개시 | Wells Fargo | Underweight |
| 2025-02-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-08 | 개시 | TD Cowen | Buy |
모두보기
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
How to escape a deep drawdown in Bicara Therapeutics Inc.Take Profit & Fast Entry High Yield Tips - Newser
Institutional scanner results for Bicara Therapeutics Inc.Rate Hike & Daily Growth Stock Investment Tips - Newser
Bicara Therapeutics Inc. stock momentum explainedMarket Trend Report & Free Technical Confirmation Trade Alerts - Newser
Bicara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Published on: 2025-08-27 14:30:15 - Newser
What momentum shifts mean for Bicara Therapeutics Inc.Weekly Earnings Recap & Weekly Breakout Opportunity Watchlist - Newser
How to track smart money flows in Bicara Therapeutics Inc.Gap Up & Free Expert Approved Momentum Trade Ideas - Newser
Is now a turning point for Bicara Therapeutics Inc.2025 Key Lessons & Smart Money Movement Tracker - Newser
Chart based exit strategy for Bicara Therapeutics Inc.Market Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
Ranking Bicara Therapeutics Inc. among high performing stocks via toolsMarket Activity Summary & Real-Time Sentiment Analysis - Newser
AI Indicators Detect Buy Opportunity in Bicara Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
What to expect from Bicara Therapeutics Inc. in the next 30 daysTrend Reversal & Weekly High Conviction Ideas - Newser
Bicara Therapeutics Inc. stock volume spike explainedBond Market & Capital Protection Trading Alerts - Newser
Visualizing Bicara Therapeutics Inc. stock with heatmapsWeekly Gains Report & Accurate Intraday Trade Tips - Newser
Top chart patterns to watch in Bicara Therapeutics Inc.Trade Performance Summary & Verified Momentum Stock Alerts - Newser
How to use Fibonacci retracement on Bicara Therapeutics Inc.Fed Meeting & Growth Focused Stock Pick Reports - Newser
Bicara Therapeutics Inc. stock trend forecastPrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Bicara Therapeutics Inc. Shows Risk Reward Favoring UpsideOil Prices & Short-Term Trading Alerts - beatles.ru
Automated trading signals detected on Bicara Therapeutics Inc.Quarterly Earnings Report & Risk Managed Investment Entry Signals - Newser
Detecting price anomalies in Bicara Therapeutics Inc. with AIJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Advanced analytics toolkit walkthrough for Bicara Therapeutics Inc.Trade Risk Assessment & Low Risk High Win Rate Picks - Newser
How to recover losses in Bicara Therapeutics Inc. stock2025 Momentum Check & Smart Money Movement Tracker - Newser
Will Bicara Therapeutics Inc. price bounce be sustainable2025 Big Picture & Low Risk Entry Point Tips - Newser
Bicara Therapeutics Inc. stock trend outlook and recovery path2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Bicara Therapeutics Inc. stock prediction for this weekWeekly Trade Report & Safe Capital Growth Plans - Newser
Can Bicara Therapeutics Inc. sustain earnings growthJuly 2025 Highlights & Community Driven Trade Alerts - theviewers.co.kr
Buybacks Report: Is Bicara Therapeutics Inc. impacted by rising rates2025 Major Catalysts & Capital Efficiency Focused Ideas - theviewers.co.kr
H.C. Wainwright lowers Bicara Therapeutics stock price target to $40 on expenses By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Bicara Therapeutics stock price target to $40 on expenses - Investing.com Nigeria
Bicara Therapeutics: HC Wainwright maintains Buy, PT lowered to $40 from $41. - AInvest
Bicara Therapeutics Inc. Stock Lags Behind Sector Benchmarks2025 Volume Leaders & Safe Entry Trade Signal Reports - newsyoung.net
Bicara Therapeutics Inc. Trading Near Value Zone — Recovery AheadRecession Risk & Verified Technical Signals - 더경남뉴스
Can swing trading help recover from Bicara Therapeutics Inc. lossesWeekly Profit Report & Daily Chart Pattern Signals - Newser
Piper Sandler initiates coverage of oncology companies - MSN
Relay Therapeutics shares fall 2.45% intraday as Piper Sandler initiates coverage on Bicara Therapeutics. - AInvest
Piper Sandler initiates coverage of oncology companies (CGON:NASDAQ) - Seeking Alpha
Piper Sandler Initiates Bicara Therapeutics at Overweight - MarketScreener
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):